The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitus
Journal
Cancers
Journal Volume
14
Journal Issue
22
Date Issued
2022-11-17
Author(s)
Abstract
Whether metformin might reduce the risk of multiple myeloma (MM) has not been extensively researched in humans.
Subjects
Taiwan; metformin; multiple myeloma; pharmacoepidemiological study; type 2 diabetes mellitus
SDGs
Publisher
MDPI
Type
journal article